Frontiers in metabolomics for cancer research: Proceedings of a National Cancer Institute workshop

Metabolomics

Volumn 4, Issue 2, 2008, Pages 105-113

  Kim, Young S ^a   Maruvada, Padma ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cancer; Metabolomics; Nutrition; Prevention; Technology

Indexed keywords

EID: 43349087355     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-008-0109-3     Document Type: Conference Paper

References (37)

1. Almaas, E., Kovacs, B., Vicsek, T., et al. (2004). Global organization of metabolic fluxes in the bacterium Escherichia coli. Nature, 427, 839-843.
2. Arias-Mendoza, F., Smith, M. R., & Brown, T. R. (2004). Predicting treatment response in non-Hodgkin's lymphoma from the pretreatment tumor content of phosphoethanolamine plus phosphocholine. Academic Radiology, 11, 368-376.
3. Boren, J., Cascante, M., Marin, S., et al. (2001). Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells. The Journal of Biological Chemistry, 276, 37747-37753.
4. 1H-NMR-based metabonomics. Nature Medicine, 8, 1439-1445.
5. Brown, S. C., Kruppa, G., & Dasseux, J. L. (2005). Metabolomics applications of FT-ICR mass spectrometry. Mass Spectrometry Reviews, 24, 223-231.
6. Cheng, L. L., Burns, M. A., Taylor, J. L., et al. (2005). Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy. Cancer Research, 65, 3030-3034.
7. Cramer, C. T., Goetz, B., Hopson, K. L., et al. (2004). Effects of a novel dual lipid synthesis inhibitor and its potential utility in treating dyslipidemia and metabolic syndrome. Journal of Lipid Research, 45, 1289-1301.
8. Duarte, N. C., Palsson, B. O., & Fu, P. (2004). Integrated analysis of metabolic phenotypes in Saccharomyces cerevisiae. BMC Genomics, 5, 63.
9. Ellis, D. I., Dunn, W. B., Griffin, J. L., et al. (2007). Metabolic fingerprinting as a diagnostic tool. Pharmacogenomics, 8, 1243-1266.
10. Fiehn, O., Kristal, B., van Ommen, B., et al. (2006). Establishing reporting standards for metabolomic and metabonomic studies: A call for participation. Omics: A Journal of Integrative Biology, 10, 158-163.
11. Griffin, J. L., & Kauppinen, R. A. (2007). A metabolomics perspective of human brain tumours. The FEBS Journal, 274, 1132-1139.
12. Griffin, J. L., & Nicholls, A. W. (2006). Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders. Pharmacogenomics, 7, 1095-1107.
13. Griffin, J. L., & Shockcor, J. P. (2004). Metabolic profiles of cancer cells. Nature Reviews. Cancer, 4, 551-561.
14. Griffiths, J. R., & Stubbs, M. (2003). Opportunities for studying cancer by metabolomics: Preliminary observations on tumors deficient in hypoxia-inducible factor 1. Advances in Enzyme Regulation, 43, 67-76.
15. 1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: Implications for the in vivo detection of apoptosis. Nature Medicine, 5, 1323-1327.
16. Hardt, P. D., Mazurek, S., Toepler, M., et al. (2004). Faecal tumour M2 pyruvate kinase: A new, sensitive screening tool for colorectal cancer. British Journal of Cancer, 91, 980-984.
17. Harkewicz, R., Fahy, E., Andreyev, A., & Dennis, E. A. (2007). Arachidonate-derived dihomoprostaglandin production observed in endotoxin-stimulated macrophage-like cells. The Journal of Biological Chemistry, 282, 2899-2910.
18. Ibarra, R. U., Fu, P., Palsson, B. O., DiTonno, J. R., & Edwards, J. S. (2003). Quantitative analysis of Escherichia coli metabolic phenotypes within the context of phenotypic phase planes. Journal of Molecular Microbiology and Biotechnology, 6, 101-108.
19. Kaddurah-Daouk, R. (2006). Metabolic profiling of patients with schizophrenia. PLoS Medicine, 3, e363.
20. Kaddurah-Daouk, R., McEvoy, J., Baillie, R. A., et al. (2007). Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Molecular Psychiatry, 12, 934-945.
21. Kell, D. B., & King, R. D. (2000). On the optimization of classes for the assignment of unidentified reading frames in functional genomics programmes: The need for machine learning. Trends in Biotechnology, 18, 93-98.
22. Lamers, R. J., DeGroot, J., Spies-Faber, E. J., et al. (2003). Identification of disease- and nutrient-related metabolic fingerprints in osteoarthritic Guinea pigs. The Journal of Nutrition, 133, 1776-1780.
23. Lee, W. N., & Go, V. L. (2005). Nutrient-gene interaction: Tracer-based metabolomics. The Journal of Nutrition, 135 (Suppl. 12), 3027S-3032S.
24. Mazurek, S., Grimm, H., Boschek, C. B., Vaupel, P., & Eigenbrodt, E. (2002). Pyruvate kinase type M2: A crossroad in the tumor metabolome. The British Journal of Nutrition, 87 (Suppl. 1), S23-S29.
25. Mendes, P. (2006). Metabolomics and the challenges ahead. Briefings in Bioinformatics, 7, 127.
26. Mendes, P., Camacho, D., & de la Fuente, A. (2005). Modelling and simulation for metabolomics data analysis. Biochemical Society Transactions, 33, 1427-1429.
27. Muoio, D. M., & Newgard, C. B. (2006). Obesity-related derangements in metabolic regulation. Annual Review of Biochemistry, 75, 367-401.
28. Nicholson, J. K., & Wilson, I. D. (2003). Opinion: Understanding 'global' systems biology: Metabonomics and the continuum of metabolism. Nature Reviews. Drug Discovery, 2, 668-676.
29. Oliver, S. G. (2002). Functional genomics: Lessons from yeast. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 357, 17-23.
30. Poitout, V., & Robertson, R. P. (2002). Minireview: Secondary beta-cell failure in type 2 diabetes - A convergence of glucotoxicity and lipotoxicity. Endocrinology, 143, 339-342.
31. Rozen, S., Cudkowicz, M. E., Bogdanov, M., et al. (2005). Metabolomic analysis and signatures in motor neuron disease. Metabolomics, 1, 101-108.
32. Salek, R. M., Maguire, M. L., Bentley, E., et al. (2007). A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and man. Physiological Genomics, 29, 99-108.
33. Sauer, U. (2006). Metabolic networks in motion: 13C-based flux analysis. Molecular Systems Biology, 2, 1-10.
34. Schipper, R. G., Romijn, J. C., Cuijpers, V. M. J. I., et al. (2003). Polyamines and prostatic cancer. Biochemical Society Transactions, 31, 375-380.
35. Serkova, N. J., Spratlin, J. L., & Eckhardt, S. G. (2007). NMR-based metabolomics: Translational application and treatment of cancer. Current Opinion in Molecular Therapeutics, 9, 572-585.
36. 1H nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile. Analytical Biochemistry, 323, 197-204.
37. Tonus, C., Neupert, G., & Sellinger, M. (2006). Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK. World Journal of Gastroenterology, 12, 7007-7011.